Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2015

Open Access 01-12-2015 | Poster presentation

Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre

Authors: Sarah Tennant, Eleanor Cornford, Jonathan James, Helen Burrell, Lisa Hamilton, Yan Chen

Published in: Breast Cancer Research | Special Issue 1/2015

Login to get access

Excerpt

Contrast-enhanced spectral mammography (CESM) is a new technology. Dual energy acquisitions during one exposure yield two sets of images: a low energy (LE) set, equivalent to standard full field digital mammography (FFDM); and a recombined set displaying contrast uptake. In our symptomatic breast service, specific patients, including those with a P4/5 clinical abnormality are offered CESM instead of FFDM. Despite encouraging data from Europe and the USA, there are, until now, no UK data to support its use in this setting. …
Metadata
Title
Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre
Authors
Sarah Tennant
Eleanor Cornford
Jonathan James
Helen Burrell
Lisa Hamilton
Yan Chen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2015
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3776

Other articles of this Special Issue 1/2015

Breast Cancer Research 1/2015 Go to the issue

Poster presentation

Comparative study of radiation dose between tomosynthesis and standard compression views in mammography

Poster presentation

Comparison of MRI and digital breast tomosynthesis in the preoperative evaluation of multifocal breast cancer

Poster presentation

Prospective study looking at CT staging for metastases in early breast cancer

Poster presentation

Safety of vacuum-assisted biopsy/mammatome guided, non-operative management of B3 lesions without atypia: a 7-year follow-up study

Poster presentation

Follow-up imaging of breast symptomatic patients: a waste of radiologist time?

Oral presentation

Breast tumour localisation using Iodine seeds in the UK: the first 100 patients

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits